These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 31254620)

  • 21. 2-Hydroxybenzylamine (2-HOBA) to prevent early recurrence of atrial fibrillation after catheter ablation: protocol for a randomized controlled trial including detection of AF using a wearable device.
    O'Neill MJ; Yoneda ZT; Crawford DM; Ye F; Ao M; Pitchford LM; Rathmacher JA; Murray KT; Akers WS; Roden DM; Michaud GF; Shoemaker MB
    Trials; 2021 Aug; 22(1):576. PubMed ID: 34454591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different roles of myocardial ROCK1 and ROCK2 in cardiac dysfunction and postcapillary pulmonary hypertension in mice.
    Sunamura S; Satoh K; Kurosawa R; Ohtsuki T; Kikuchi N; Elias-Al-Mamun M; Shimizu T; Ikeda S; Suzuki K; Satoh T; Omura J; Nogi M; Numano K; Siddique MAH; Miyata S; Miura M; Shimokawa H
    Proc Natl Acad Sci U S A; 2018 Jul; 115(30):E7129-E7138. PubMed ID: 29987023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The disruption of invariant natural killer T cells exacerbates cardiac hypertrophy and failure caused by pressure overload in mice.
    Takahashi M; Kinugawa S; Takada S; Kakutani N; Furihata T; Sobirin MA; Fukushima A; Obata Y; Saito A; Ishimori N; Iwabuchi K; Tsutsui H
    Exp Physiol; 2020 Mar; 105(3):489-501. PubMed ID: 31957919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
    Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
    Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
    Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
    Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenosine kinase attenuates cardiomyocyte microtubule stabilization and protects against pressure overload-induced hypertrophy and LV dysfunction.
    Fassett J; Xu X; Kwak D; Zhu G; Fassett EK; Zhang P; Wang H; Mayer B; Bache RJ; Chen Y
    J Mol Cell Cardiol; 2019 May; 130():49-58. PubMed ID: 30910669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of cardiac remodeling by pravastatin is associated with amelioration of endoplasmic reticulum stress.
    Zhao H; Liao Y; Minamino T; Asano Y; Asakura M; Kim J; Asanuma H; Takashima S; Hori M; Kitakaze M
    Hypertens Res; 2008 Oct; 31(10):1977-87. PubMed ID: 19015605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short term Pm2.5 exposure caused a robust lung inflammation, vascular remodeling, and exacerbated transition from left ventricular failure to right ventricular hypertrophy.
    Yue W; Tong L; Liu X; Weng X; Chen X; Wang D; Dudley SC; Weir EK; Ding W; Lu Z; Xu Y; Chen Y
    Redox Biol; 2019 Apr; 22():101161. PubMed ID: 30861460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmented endothelial l-arginine transport ameliorates pressure-overload-induced cardiac hypertrophy.
    Rajapakse NW; Johnston T; Kiriazis H; Chin-Dusting JP; Du XJ; Kaye DM
    Exp Physiol; 2015 Jul; 100(7):796-804. PubMed ID: 25958845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
    Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
    Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of plasma glucose with alpha-glucosidase inhibitor attenuates oxidative stress and slows the progression of heart failure in mice.
    Liao Y; Takashima S; Zhao H; Asano Y; Shintani Y; Minamino T; Kim J; Fujita M; Hori M; Kitakaze M
    Cardiovasc Res; 2006 Apr; 70(1):107-16. PubMed ID: 16510136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective Roles of Interferon-γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload.
    Kimura A; Ishida Y; Furuta M; Nosaka M; Kuninaka Y; Taruya A; Mukaida N; Kondo T
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29555642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing Regulatory T Cells With Interleukin-2 and Interleukin-2 Antibody Complexes Attenuates Lung Inflammation and Heart Failure Progression.
    Wang H; Hou L; Kwak D; Fassett J; Xu X; Chen A; Chen W; Blazar BR; Xu Y; Hall JL; Ge JB; Bache RJ; Chen Y
    Hypertension; 2016 Jul; 68(1):114-22. PubMed ID: 27160197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zerumbone prevents pressure overload-induced left ventricular systolic dysfunction by inhibiting cardiac hypertrophy and fibrosis.
    Sari N; Katanasaka Y; Sugiyama Y; Sunagawa Y; Miyazaki Y; Funamoto M; Shimizu S; Shimizu K; Murakami A; Mori K; Wada H; Hasegawa K; Morimoto T
    Phytomedicine; 2021 Nov; 92():153744. PubMed ID: 34563985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
    Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
    Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide synthase 3 deficiency limits adverse ventricular remodeling after pressure overload in insulin resistance.
    Kurtz B; Thibault HB; Raher MJ; Popovich JR; Cawley S; Atochin DN; Hayton S; Shakartzi HR; Huang PL; Bloch KD; Buys E; Scherrer-Crosbie M
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2093-101. PubMed ID: 21856905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
    Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolevuglandin-Modified Cardiac Proteins Drive CD4+ T-Cell Activation in the Heart and Promote Cardiac Dysfunction.
    Ngwenyama N; Kirabo A; Aronovitz M; Velázquez F; Carrillo-Salinas F; Salvador AM; Nevers T; Amarnath V; Tai A; Blanton RM; Harrison DG; Alcaide P
    Circulation; 2021 Mar; 143(12):1242-1255. PubMed ID: 33463362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular high-mobility group box 1 mediates pressure overload-induced cardiac hypertrophy and heart failure.
    Zhang L; Liu M; Jiang H; Yu Y; Yu P; Tong R; Wu J; Zhang S; Yao K; Zou Y; Ge J
    J Cell Mol Med; 2016 Mar; 20(3):459-70. PubMed ID: 26647902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytosolic DNA sensor cGAS plays an essential pathogenetic role in pressure overload-induced heart failure.
    Hu D; Cui YX; Wu MY; Li L; Su LN; Lian Z; Chen H
    Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1525-H1537. PubMed ID: 32383996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.